Iwo Kucinski

Iwo Kucinski began their work experience in 2016 as a Research Associate at the University of Cambridge. They held this role until 2022. In 2022, they joined Xap Therapeutics as a Principal Scientist, and their current employment is ongoing.

Iwo Kucinski's education history begins in 2008 when they enrolled at the University of Warsaw to pursue a Bachelor of Science degree in Biotechnology. Iwo graduated from this program in 2010. Following this, they continued their education at the same university and obtained a Master of Science degree in Molecular Biology from 2010 to 2011.

In 2011, Iwo Kucinski joined the University of Cambridge to study Developmental Biology and Embryology. Iwo completed a Master of Philosophy degree in this field from 2011 to 2012. Iwo continued their studies at the University of Cambridge and achieved a Doctor of Philosophy degree in Developmental Biology and Embryology from 2012 to 2016.

Overall, Iwo Kucinski's educational journey encompassed their studies in Biotechnology and Molecular Biology at the University of Warsaw, followed by their advanced studies in Developmental Biology and Embryology at the University of Cambridge.